Pharmafile Logo
Pharmafocus logo
Advanced Search

MHRA and EC approve Leo Pharma’s Adtralza for atopic dermatitis

June 24, 2021

The MHRA and EC have approved Leo Pharma’s Adtralza (tralokinumab) for adults with moderate-to-severe atopic dermatitis who are candidates for …

News

Anti-parasitic drug investigated as potential COVID treatment

June 23, 2021
Research and Development

The University of Oxford has announced that it has begun investigations into ivermectin, a controversial anti-parasitic drug, as a potential …

News
astrazeneca_sign_sky

AstraZeneca’s lung cancer treatment approved in China

June 23, 2021
Research and Development

AstraZeneca and HUTCHMED’s savolitinib has been granted conditional approval in China for the treatment of patients with non-small cell lung …

News
european_commission_web

Extra 150 million doses of Moderna COVID jab bought by EC

June 23, 2021
Research and Development

Moderna have announced that the European Commission (EC) has purchased an additional 150 million doses of their COVID-19 vaccine, bringing …

News
janssen_latest_logo_on_sign_closer

EU approves Janssen’s treatments for amyloidosis and multiple myeloma

June 23, 2021
Research and Development

The EU has approved Janssen’s DARZALEX SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment …

News

Vectura announces cannabinoid company collaboration for TBI treatment

June 23, 2021
Research and Development

Vectura have announced the signing of a pre-clinical development agreement with Incannex, an Australian cannabinoid medicines development company, to provide …

News
dna-163466_1280

Biotage launches new automated platform for plasmid DNA purification

June 22, 2021
Manufacturing and Production

Biotage has launched PhyPrep, a new automated platform for plasmid DNA purification. With the new Biotage PhyPrep platform, the automated …

News
takeda_wien

Takeda collaboration to optimise biopharmaceutical manufacturing announced

June 22, 2021
Manufacturing and Production Takeda, collaboration, manufacturing

A 36-month joint project between Takeda’s manufacturing site in Vienna, the Research Center Pharmaceutical Engineering (RCPE), InSilicoTrials, and the University …

News
andrei_r_-_shutterstock_1935537274_720

LegoChem and Iksuda expand License Agreement for antibody drug conjugates

June 22, 2021
Manufacturing and Production ADC, License Agreement, deal, technology

Iksuda Therapeutics, a developer of antibody drug conjugates (ADCs), has announced the expansion of the research collaboration and License Agreement …

News

Insect-based vaccine production platform validated by EMA

June 22, 2021
Manufacturing and Production Insect-based, Vaccine, production, technology

Algenex SL has announced EMA validation of a recombinant subunit vaccine produced by their baculovirus vector-mediated expression platform, that harnesses …

News

GSK’s ViiV and Halozyme to collaborate on ‘ultra-long acting’ HIV drugs

June 22, 2021
Manufacturing and Production GSK, HIV, ViiV Healthcare

ViiV Healthcare, the specialist HIV company majority owned by GlaxoSmithKline (GSK), is to collaborate with Halozyme Therapeutics, giving it exclusive …

News
astrazeneca_plaque_web

AstraZeneca ordered to deliver 50 million vaccine doses to EU

June 21, 2021
Sales and Marketing

A Belgian court has instructed AstraZeneca to deliver 50 million COVID-19 shots to the European Union following a dispute on …

News

EU approves Onureg for patients with acute myeloid leukemia

June 21, 2021
Sales and Marketing

The European Commission has approved Onureg as frontline oral maintenance therapy for patients with a broad range of acute myeloid …

News

Alzheimer’s drug approval: Advocacy group calls for FDA resignations

June 21, 2021
Sales and Marketing

Public Citizen, the US consumer advocacy group, has called for the resignation of three top FDA officials following the approval …

News
novartis_window

Novartis’s Zolgensma for SMA shows ‘extraordinary’ results

June 21, 2021
Sales and Marketing

New late-breaker data from the Phase III trial for Zolgensma, the world’s most expensive drug, has shown positive results. Zolgensma …

News
sanofi_hq__boetie_hall_web

EU approves Aubagio for children living with MS

June 21, 2021
Sales and Marketing

The EU has approved Aubagio (teriflunomide) for the treatment of paediatric patients 10 to 17 years of age with relapsing-remitting …

News

Breakthrough announced in circulating tumour cell research

June 18, 2021
Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology

Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …

News

UK AI firm wins share of £140 million funding for lung cancer detection tech

June 18, 2021
Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology

Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …

News
astrazeneca_plaque

Australia pauses AstraZeneca vaccine for people under 60

June 18, 2021
Medical Communications AstraZeneca, Australia, COVID-19, Vaccine

Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …

News

New class of cancer-killing drugs identified

June 18, 2021
Medical Communications Cancer, oncology

Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026